Zydus Recalls BUPROPION Hydrochloride Extended-Release Tablets for Dissolution Failure
Zydus Pharmaceuticals USA Inc. is recalling BUPROPION Hydrochloride Extended-Release Tablets, 300 mg, because the product failed to meet dissolution specifications at an intermediate time point.
- Product
- BUPROPION — BUPROPION (BUPROPION)
- Category
- Drug
- Distribution
- Distributed nationwide